Cargando…

Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area

Transmission chains within small urban areas (accommodating ∼30 per cent of the European population) greatly contribute to case burden and economic impact during the ongoing coronavirus pandemic and should be a focus for preventive measures to achieve containment. Here, at very high spatio-temporal...

Descripción completa

Detalles Bibliográficos
Autores principales: Brüningk, Sarah C, Klatt, Juliane, Stange, Madlen, Mari, Alfredo, Brunner, Myrta, Roloff, Tim-Christoph, Seth-Smith, Helena M B, Schweitzer, Michael, Leuzinger, Karoline, Søgaard, Kirstine K, Albertos Torres, Diana, Gensch, Alexander, Schlotterbeck, Ann-Kathrin, Nickel, Christian H, Ritz, Nicole, Heininger, Ulrich, Bielicki, Julia, Rentsch, Katharina, Fuchs, Simon, Bingisser, Roland, Siegemund, Martin, Pargger, Hans, Ciardo, Diana, Dubuis, Olivier, Buser, Andreas, Tschudin-Sutter, Sarah, Battegay, Manuel, Schneider-Sliwa, Rita, Borgwardt, Karsten M, Hirsch, Hans H, Egli, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927799/
https://www.ncbi.nlm.nih.gov/pubmed/35310621
http://dx.doi.org/10.1093/ve/veac002
_version_ 1784670523919171584
author Brüningk, Sarah C
Klatt, Juliane
Stange, Madlen
Mari, Alfredo
Brunner, Myrta
Roloff, Tim-Christoph
Seth-Smith, Helena M B
Schweitzer, Michael
Leuzinger, Karoline
Søgaard, Kirstine K
Albertos Torres, Diana
Gensch, Alexander
Schlotterbeck, Ann-Kathrin
Nickel, Christian H
Ritz, Nicole
Heininger, Ulrich
Bielicki, Julia
Rentsch, Katharina
Fuchs, Simon
Bingisser, Roland
Siegemund, Martin
Pargger, Hans
Ciardo, Diana
Dubuis, Olivier
Buser, Andreas
Tschudin-Sutter, Sarah
Battegay, Manuel
Schneider-Sliwa, Rita
Borgwardt, Karsten M
Hirsch, Hans H
Egli, Adrian
author_facet Brüningk, Sarah C
Klatt, Juliane
Stange, Madlen
Mari, Alfredo
Brunner, Myrta
Roloff, Tim-Christoph
Seth-Smith, Helena M B
Schweitzer, Michael
Leuzinger, Karoline
Søgaard, Kirstine K
Albertos Torres, Diana
Gensch, Alexander
Schlotterbeck, Ann-Kathrin
Nickel, Christian H
Ritz, Nicole
Heininger, Ulrich
Bielicki, Julia
Rentsch, Katharina
Fuchs, Simon
Bingisser, Roland
Siegemund, Martin
Pargger, Hans
Ciardo, Diana
Dubuis, Olivier
Buser, Andreas
Tschudin-Sutter, Sarah
Battegay, Manuel
Schneider-Sliwa, Rita
Borgwardt, Karsten M
Hirsch, Hans H
Egli, Adrian
author_sort Brüningk, Sarah C
collection PubMed
description Transmission chains within small urban areas (accommodating ∼30 per cent of the European population) greatly contribute to case burden and economic impact during the ongoing coronavirus pandemic and should be a focus for preventive measures to achieve containment. Here, at very high spatio-temporal resolution, we analysed determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in a European urban area, Basel-City (Switzerland). We combined detailed epidemiological, intra-city mobility and socio-economic data sets with whole-genome sequencing during the first SARS-CoV-2 wave. For this, we succeeded in sequencing 44 per cent of all reported cases from Basel-City and performed phylogenetic clustering and compartmental modelling based on the dominating viral variant (B.1-C15324T; 60 per cent of cases) to identify drivers and patterns of transmission. Based on these results we simulated vaccination scenarios and corresponding healthcare system burden (intensive care unit (ICU) occupancy). Transmissions were driven by socio-economically weaker and highly mobile population groups with mostly cryptic transmissions which lacked genetic and identifiable epidemiological links. Amongst more senior population transmission was clustered. Simulated vaccination scenarios assuming 60–90 per cent transmission reduction and 70–90 per cent reduction of severe cases showed that prioritising mobile, socio-economically weaker populations for vaccination would effectively reduce case numbers. However, long-term ICU occupation would also be effectively reduced if senior population groups were prioritised, provided there were no changes in testing and prevention strategies. Reducing SARS-CoV-2 transmission through vaccination strongly depends on the efficacy of the deployed vaccine. A combined strategy of protecting risk groups by extensive testing coupled with vaccination of the drivers of transmission (i.e. highly mobile groups) would be most effective at reducing the spread of SARS-CoV-2 within an urban area.
format Online
Article
Text
id pubmed-8927799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89277992022-03-17 Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area Brüningk, Sarah C Klatt, Juliane Stange, Madlen Mari, Alfredo Brunner, Myrta Roloff, Tim-Christoph Seth-Smith, Helena M B Schweitzer, Michael Leuzinger, Karoline Søgaard, Kirstine K Albertos Torres, Diana Gensch, Alexander Schlotterbeck, Ann-Kathrin Nickel, Christian H Ritz, Nicole Heininger, Ulrich Bielicki, Julia Rentsch, Katharina Fuchs, Simon Bingisser, Roland Siegemund, Martin Pargger, Hans Ciardo, Diana Dubuis, Olivier Buser, Andreas Tschudin-Sutter, Sarah Battegay, Manuel Schneider-Sliwa, Rita Borgwardt, Karsten M Hirsch, Hans H Egli, Adrian Virus Evol Research Article Transmission chains within small urban areas (accommodating ∼30 per cent of the European population) greatly contribute to case burden and economic impact during the ongoing coronavirus pandemic and should be a focus for preventive measures to achieve containment. Here, at very high spatio-temporal resolution, we analysed determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in a European urban area, Basel-City (Switzerland). We combined detailed epidemiological, intra-city mobility and socio-economic data sets with whole-genome sequencing during the first SARS-CoV-2 wave. For this, we succeeded in sequencing 44 per cent of all reported cases from Basel-City and performed phylogenetic clustering and compartmental modelling based on the dominating viral variant (B.1-C15324T; 60 per cent of cases) to identify drivers and patterns of transmission. Based on these results we simulated vaccination scenarios and corresponding healthcare system burden (intensive care unit (ICU) occupancy). Transmissions were driven by socio-economically weaker and highly mobile population groups with mostly cryptic transmissions which lacked genetic and identifiable epidemiological links. Amongst more senior population transmission was clustered. Simulated vaccination scenarios assuming 60–90 per cent transmission reduction and 70–90 per cent reduction of severe cases showed that prioritising mobile, socio-economically weaker populations for vaccination would effectively reduce case numbers. However, long-term ICU occupation would also be effectively reduced if senior population groups were prioritised, provided there were no changes in testing and prevention strategies. Reducing SARS-CoV-2 transmission through vaccination strongly depends on the efficacy of the deployed vaccine. A combined strategy of protecting risk groups by extensive testing coupled with vaccination of the drivers of transmission (i.e. highly mobile groups) would be most effective at reducing the spread of SARS-CoV-2 within an urban area. Oxford University Press 2022-03-17 /pmc/articles/PMC8927799/ /pubmed/35310621 http://dx.doi.org/10.1093/ve/veac002 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Brüningk, Sarah C
Klatt, Juliane
Stange, Madlen
Mari, Alfredo
Brunner, Myrta
Roloff, Tim-Christoph
Seth-Smith, Helena M B
Schweitzer, Michael
Leuzinger, Karoline
Søgaard, Kirstine K
Albertos Torres, Diana
Gensch, Alexander
Schlotterbeck, Ann-Kathrin
Nickel, Christian H
Ritz, Nicole
Heininger, Ulrich
Bielicki, Julia
Rentsch, Katharina
Fuchs, Simon
Bingisser, Roland
Siegemund, Martin
Pargger, Hans
Ciardo, Diana
Dubuis, Olivier
Buser, Andreas
Tschudin-Sutter, Sarah
Battegay, Manuel
Schneider-Sliwa, Rita
Borgwardt, Karsten M
Hirsch, Hans H
Egli, Adrian
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title_full Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title_fullStr Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title_full_unstemmed Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title_short Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
title_sort determinants of sars-cov-2 transmission to guide vaccination strategy in an urban area
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927799/
https://www.ncbi.nlm.nih.gov/pubmed/35310621
http://dx.doi.org/10.1093/ve/veac002
work_keys_str_mv AT bruningksarahc determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT klattjuliane determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT stangemadlen determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT marialfredo determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT brunnermyrta determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT rolofftimchristoph determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT sethsmithhelenamb determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT schweitzermichael determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT leuzingerkaroline determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT søgaardkirstinek determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT albertostorresdiana determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT genschalexander determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT schlotterbeckannkathrin determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT nickelchristianh determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT ritznicole determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT heiningerulrich determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT bielickijulia determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT rentschkatharina determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT fuchssimon determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT bingisserroland determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT siegemundmartin determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT parggerhans determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT ciardodiana determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT dubuisolivier determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT buserandreas determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT tschudinsuttersarah determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT battegaymanuel determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT schneidersliwarita determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT borgwardtkarstenm determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT hirschhansh determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea
AT egliadrian determinantsofsarscov2transmissiontoguidevaccinationstrategyinanurbanarea